Phase II Trial of the electrocutaneous nerve stimulation device, MC5-A Calmare. In patiens with refractory chemotherapy induced peripheral neuropathy

2.3 MEETING ASCO 2010 – Poster

Phase II Trial of the electrocutaneous nerve stimulation device, MC5-A Calmare. In patiens with refractory chemotherapy induced peripheral neuropathy

Thomas J. Smith, Patrick J. Coyne, Patricia A. Dodson, Gwendolyn Parker, V. Ramakrishman
Virginia CommoNwealth University Massey Cancer Center